Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9309965 | 0.83 | MEN1 (0.31) | KDM4CGRM5MEN1KMT2A | |
| SCHEMBL9164573 | 0.83 | MEN1 (0.31) | KDM4CGRM5MEN1KMT2A | |
| SCHEMBL28921025 | 0.82 | MEN1 (0.39) | KDM4CMEN1KMT2AL3MBTL1NPC1 | |
| SCHEMBL26905400 | 0.82 | MEN1 (0.39) | KDM4CMEN1KMT2AL3MBTL1NPC1 | |
| SCHEMBL28961633 | 0.82 | MEN1 (0.39) | KDM4CMEN1KMT2AL3MBTL1NPC1 | |
| SCHEMBL10576592 | 0.81 | MEN1 (0.38) | KDM4CGRM5MEN1KMT2AL3MBTL1 | |
| SCHEMBL9309065 | 0.81 | KDM4C (0.32) | KDM4CGRM5NPC1RAB9A | |
| SCHEMBL2984108 | 0.77 | MEN1 (0.37) | KDM4CGRM5MEN1KMT2AL3MBTL1 | |
| SCHEMBL1921106 | 0.77 | MEN1 (0.34) | KDM4CGRM5MEN1KMT2AL3MBTL1 | |
| SCHEMBL11813613 | 0.76 | MEN1 (0.35) | KDM4CGRM5MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5318989-A | Antitumor and -carcinogenic agents; antibiotics; aglycones of esperamycins and calichemicins and having the same mechanism of bioactivity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-06-07 | — | — | US | disclosed |
| EP-0538898-A2 | Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof | Bristol-Myers Squibb Company (US) | 1993-04-28 | — | — | EP | disclosed |
| US-5198560-A | Antitumor agents based on esperamicin antibiotics | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-03-30 | — | — | US | disclosed |
| EP-0454146-A1 | Cytotoxic bicyclo[7.3.1] tridec-4-ene-2,6-diyne compounds and process for the preparation thereof | Bristol-Myers Squibb Company (US) | 1991-10-30 | — | — | EP | disclosed |